Enanta Pharmaceuticals, Inc.
|
Common Stock
|
29251M106
|
December 31, 2014
|
CUSIP No. 29251M106
|
13G
|
Page 2 of 10
|
Item 1(a).
|
Name of Issuer:
|
Item 1(b).
|
Address of Issuer's Principal Executive Offices:
|
Item 2(a).
|
Name of Persons Filing:
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
Item 2(c).
|
Citizenship:
|
Item 2(d).
|
Title of Class of Securities:
|
Item 2(e).
|
CUSIP Number:
|
Item 3.
|
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
CUSIP No. 29251M106
|
13G
|
Page 3 of 10
|
Item 4.
|
Ownership.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
CUSIP No. 29251M106
|
13G
|
Page 4 of 10
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
CUSIP No. 29251M106
|
13G
|
Page 5 of 10
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
*
|
*
|
*
|
CUSIP No. 29251M106
|
13G
|
Page 6 of 10
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
CUSIP No. 29251M106
|
13G
|
Page 7 of 10
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
|
Name: Stefan Fischer
|
|
Title: Authorized Officer
|
*
|
*
|
*
|
CUSIP No. 29251M106
|
13G
|
Page 8 of 10
|
CUSIP No. 29251M106
|
13G
|
Page 9 of 10
|
CUSIP No. 29251M106
|
13G
|
Page 10 of 10
|